{"KILITCH.NS": {"assetProfile": {"address1": "37/39, Ujagar Industrial Estate", "address2": "Waman Tukaram Patil Marg Deonar", "city": "Mumbai", "zip": "400088", "country": "India", "phone": "91 22 6121 4100", "fax": "91 22 6703 1658", "website": "http://www.kilitch.com", "industry": "Drug Manufacturers\u2014General", "sector": "Healthcare", "longBusinessSummary": "Kilitch Drugs (India) Limited engages in the development and operation of pharmaceutical business in India. The company offers parenteral and nasal products, including gastroenterology, anti-inflammatory, anticonvulsant/antiepileptic, anti-malarial, aminoglycoside, antibacterial, anti-hypertensive, anti-infective, diagnostic, sympathomimetic, local anesthetic, neurotonic, uterine stimulant, external preparation, non-steroidal anti-inflammatory, oncology, ophthalmic, and other drugs, as well as vaccines and veterinary products in the form of ampoules, vials, and dry powder injectables. Its parenteral and nasal products also include iron supplements for the treatment of anemia; and metered nasal drops, as well as Klavmox and Onecef products. The company also provides a range of oral formulations, including tablets, capsules, dry syrups, gripe water, and oral powders and liquids in the antibiotic, anti-diabetics, cardiovascular, and other areas. In addition, it offers effervescent tablets and powders, such as ROIPAR, DUREGRA, ROIVIT, and PH-7; and a range of nutritional products comprising CELTINE. Further, the company provides C-Seal, a topical skin adhesive to hold closely approximated skin edges without marks of sutures and incisions. Additionally, it offers cosmetics and herbal products consisting of a range of oils, lotions, liquids, creams, and paste in skin, personal, and hair care categories, as well as herbal products used in sore throat and prostate problems; and as a supplement for diabetes, obesity, libido, and other conditions. The company also exports its products. Kilitch Drugs (India) Limited was founded in 1978 and is headquartered in Mumbai, India.", "fullTimeEmployees": 111, "companyOfficers": [{"maxAge": 1, "name": "Mr. Mukund Prataprai Mehta", "age": 67, "title": "Exec. Chairman & MD", "yearBorn": 1953, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Sujit Kumar Dash", "age": 33, "title": "Chief Financial Officer", "yearBorn": 1987, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bhavin Mukund Mehta", "age": 43, "title": "Whole-time Director", "yearBorn": 1977, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mira Bhavin Mehta", "age": 41, "title": "Whole Time Director", "yearBorn": 1979, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sunita Naranbhai Gohil", "age": 23, "title": "Company Sec. & Compliance Officer", "yearBorn": 1997, "exercisedValue": 0, "unexercisedValue": 0}], "maxAge": 86400}, "recommendationTrend": {"trend": [{"period": "0m", "strongBuy": 0, "buy": 0, "hold": 0, "sell": 0, "strongSell": 0}, {"period": "-1m", "strongBuy": 0, "buy": 0, "hold": 0, "sell": 0, "strongSell": 0}, {"period": "-2m", "strongBuy": 0, "buy": 0, "hold": 0, "sell": 0, "strongSell": 0}, {"period": "-3m", "strongBuy": 0, "buy": 0, "hold": 0, "sell": 0, "strongSell": 0}], "maxAge": 86400}, "cashflowStatementHistory": {"cashflowStatements": [{"maxAge": 1, "endDate": "2020-03-31", "netIncome": 8420000, "depreciation": 11546000, "changeToNetincome": -45853000, "changeToAccountReceivables": 55128000, "changeToLiabilities": 28482000, "changeToInventory": -8409000, "changeToOperatingActivities": -11882000, "totalCashFromOperatingActivities": 37451000, "capitalExpenditures": -104993000, "investments": 3104000, "otherCashflowsFromInvestingActivities": -2651000, "totalCashflowsFromInvestingActivities": -104540000, "dividendsPaid": -17903000, "netBorrowings": 31550000, "otherCashflowsFromFinancingActivities": 1217000, "totalCashFromFinancingActivities": 15654000, "changeInCash": -51435000, "issuanceOfStock": 790000}, {"maxAge": 1, "endDate": "2019-03-31", "netIncome": 38298000, "depreciation": 11971000, "changeToNetincome": 12376000, "changeToAccountReceivables": -12830000, "changeToLiabilities": -31941000, "changeToInventory": -19194000, "changeToOperatingActivities": 4114000, "totalCashFromOperatingActivities": 2909000, "capitalExpenditures": -190217000, "investments": 38506000, "otherCashflowsFromInvestingActivities": 11925000, "totalCashflowsFromInvestingActivities": -139786000, "dividendsPaid": -9504000, "netBorrowings": 85325000, "otherCashflowsFromFinancingActivities": 22234000, "totalCashFromFinancingActivities": 168553000, "changeInCash": 31675000, "issuanceOfStock": 70498000}, {"maxAge": 1, "endDate": "2018-03-31", "netIncome": 51526000, "depreciation": 11930000, "changeToNetincome": 17568000, "changeToAccountReceivables": -80460000, "changeToLiabilities": 23769000, "changeToInventory": -2012000, "changeToOperatingActivities": -8328000, "totalCashFromOperatingActivities": 14231000, "capitalExpenditures": -34881000, "investments": -12314000, "otherCashflowsFromInvestingActivities": 2691000, "totalCashflowsFromInvestingActivities": -44504000, "dividendsPaid": -408000, "netBorrowings": 2366000, "otherCashflowsFromFinancingActivities": 23600000, "totalCashFromFinancingActivities": 55058000, "changeInCash": 24786000, "issuanceOfStock": 29500000}, {"maxAge": 1, "endDate": "2017-03-31", "netIncome": -88896000, "depreciation": 13193000, "changeToNetincome": 97477000, "changeToAccountReceivables": -34120000, "changeToLiabilities": 24916000, "changeToInventory": 256000, "changeToOperatingActivities": -1886000, "totalCashFromOperatingActivities": 11214000, "capitalExpenditures": -13284000, "investments": 2003000, "otherCashflowsFromInvestingActivities": -4061000, "totalCashflowsFromInvestingActivities": -15342000, "dividendsPaid": -403000, "netBorrowings": 2366000, "otherCashflowsFromFinancingActivities": 23600000, "totalCashFromFinancingActivities": -403000, "changeInCash": -4531000, "issuanceOfStock": 29500000}], "maxAge": 86400}, "indexTrend": {"maxAge": 1, "symbol": "SP5", "peRatio": 19.7411, "pegRatio": 1.34172, "estimates": [{"period": "0q", "growth": 0.549}, {"period": "+1q", "growth": 0.431}, {"period": "0y", "growth": 0.305}, {"period": "+1y", "growth": 0.109}, {"period": "+5y", "growth": 0.120865}, {"period": "-5y"}]}, "defaultKeyStatistics": {"maxAge": 1, "priceHint": 2, "enterpriseValue": 1435076480, "profitMargins": 0.02849, "floatShares": 3430617, "sharesOutstanding": 15494500, "heldPercentInsiders": 0.72807, "heldPercentInstitutions": 0.0, "beta": 0.746916, "category": null, "bookValue": 78.507, "priceToBook": 1.3521087, "fundFamily": null, "legalType": null, "lastFiscalYearEnd": "2020-03-31 05:30:00", "nextFiscalYearEnd": "2022-03-31 05:30:00", "mostRecentQuarter": "2020-12-31 05:30:00", "earningsQuarterlyGrowth": 1.343, "netIncomeToCommon": 17154000, "trailingEps": 1.104, "lastSplitFactor": null, "enterpriseToRevenue": 2.383, "enterpriseToEbitda": 54.462}, "industryTrend": {"maxAge": 1, "symbol": null, "estimates": []}, "quoteType": {"exchange": "NSI", "quoteType": "EQUITY", "symbol": "KILITCH.NS", "underlyingSymbol": "KILITCH.NS", "shortName": "KILITCH DRUGS(INDI", "longName": "Kilitch Drugs (India) Limited", "firstTradeDateEpochUtc": "2010-09-29 09:15:00", "timeZoneFullName": "Asia/Kolkata", "timeZoneShortName": "IST", "uuid": "8de1eb57-878d-3be4-a094-0f223b87abd9", "gmtOffSetMilliseconds": 19800000, "maxAge": 1}, "incomeStatementHistory": {"incomeStatementHistory": [{"maxAge": 1, "endDate": "2020-03-31", "totalRevenue": 533200000, "costOfRevenue": 297732000, "grossProfit": 235468000, "researchDevelopment": {}, "sellingGeneralAdministrative": 101716000, "nonRecurring": {}, "otherOperatingExpenses": 130625000, "totalOperatingExpenses": 541638000, "operatingIncome": -8438000, "totalOtherIncomeExpenseNet": 24511000, "ebit": -8438000, "interestExpense": -7159000, "incomeBeforeTax": 16073000, "incomeTaxExpense": 7653000, "minorityInterest": 22183000, "netIncomeFromContinuingOps": 8420000, "discontinuedOperations": {}, "extraordinaryItems": {}, "effectOfAccountingCharges": {}, "otherItems": {}, "netIncome": 8420000, "netIncomeApplicableToCommonShares": 8420000}, {"maxAge": 1, "endDate": "2019-03-31", "totalRevenue": 824899000, "costOfRevenue": 490151000, "grossProfit": 334748000, "researchDevelopment": {}, "sellingGeneralAdministrative": 121230000, "nonRecurring": {}, "otherOperatingExpenses": 132733000, "totalOperatingExpenses": 756200000, "operatingIncome": 68699000, "totalOtherIncomeExpenseNet": 17167000, "ebit": 68699000, "interestExpense": -3791000, "incomeBeforeTax": 85866000, "incomeTaxExpense": 47568000, "minorityInterest": 20966000, "netIncomeFromContinuingOps": 38298000, "discontinuedOperations": {}, "extraordinaryItems": {}, "effectOfAccountingCharges": {}, "otherItems": {}, "netIncome": 38298000, "netIncomeApplicableToCommonShares": 38298000}, {"maxAge": 1, "endDate": "2018-03-31", "totalRevenue": 510118000, "costOfRevenue": 267547000, "grossProfit": 242571000, "researchDevelopment": {}, "sellingGeneralAdministrative": 76966000, "nonRecurring": {}, "otherOperatingExpenses": 108454000, "totalOperatingExpenses": 464963000, "operatingIncome": 45155000, "totalOtherIncomeExpenseNet": 15974000, "ebit": 45155000, "interestExpense": -3791000, "incomeBeforeTax": 61129000, "incomeTaxExpense": 9603000, "minorityInterest": 7313000, "netIncomeFromContinuingOps": 51526000, "discontinuedOperations": {}, "extraordinaryItems": {}, "effectOfAccountingCharges": {}, "otherItems": {}, "netIncome": 51526000, "netIncomeApplicableToCommonShares": 51526000}, {"maxAge": 1, "endDate": "2017-03-31", "totalRevenue": 286525000, "costOfRevenue": 121305000, "grossProfit": 165220000, "researchDevelopment": {}, "sellingGeneralAdministrative": 172201000, "nonRecurring": {}, "otherOperatingExpenses": -5074000, "totalOperatingExpenses": 301727000, "operatingIncome": -15202000, "totalOtherIncomeExpenseNet": -77950000, "ebit": -15202000, "interestExpense": -3791000, "incomeBeforeTax": -93152000, "incomeTaxExpense": -4256000, "minorityInterest": 7313000, "netIncomeFromContinuingOps": -88896000, "discontinuedOperations": {}, "extraordinaryItems": {}, "effectOfAccountingCharges": {}, "otherItems": {}, "netIncome": -88896000, "netIncomeApplicableToCommonShares": -88896000}], "maxAge": 86400}, "fundOwnership": {"ownershipList": [], "maxAge": 1}, "summaryDetail": {"maxAge": 1, "priceHint": 2, "previousClose": 103.3, "open": 103.3, "dayLow": 100.85, "dayHigh": 110.9, "regularMarketPreviousClose": 103.3, "regularMarketOpen": 103.3, "regularMarketDayLow": 100.85, "regularMarketDayHigh": 110.9, "exDividendDate": "2019-09-20 05:30:00", "payoutRatio": 0.0, "beta": 0.746916, "trailingPE": 96.15037, "volume": 39979, "regularMarketVolume": 39979, "averageVolume": 7627, "averageVolume10days": 5758, "averageDailyVolume10Day": 5758, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 1626430336, "fiftyTwoWeekLow": 78.6, "fiftyTwoWeekHigh": 139.0, "priceToSalesTrailing12Months": 2.7010744, "fiftyDayAverage": 85.42941, "twoHundredDayAverage": 90.7039, "trailingAnnualDividendRate": 0.5, "trailingAnnualDividendYield": 0.004840271, "currency": "INR", "fromCurrency": null, "lastMarket": null, "algorithm": null, "tradeable": false}, "insiderHolders": {"holders": [{"maxAge": 1, "name": "Kilitch Company Pharma Ltd", "relation": "Institution- Corporation", "url": "", "transactionDescription": "Acquisition", "latestTransDate": "2012-09-21", "positionDirect": 6629342, "positionDirectDate": "2012-09-21"}, {"maxAge": 1, "name": "Mehta (Bhavin)", "relation": "Wholetime Director", "url": "", "transactionDescription": "Other", "latestTransDate": "2019-06-27", "positionDirect": 2002416, "positionDirectDate": "2019-06-27"}, {"maxAge": 1, "name": "Mehta (Mukund Prataprai)", "relation": "Managing Director", "url": "", "transactionDescription": "Other", "latestTransDate": "2019-06-27", "positionDirect": 890647, "positionDirectDate": "2019-06-27"}, {"maxAge": 1, "name": "Mehta (Neeta Mukund)", "relation": "Promoter", "url": "", "transactionDescription": "Other", "latestTransDate": "2018-03-29", "positionDirect": 484768, "positionDirectDate": "2018-03-29"}, {"maxAge": 1, "name": "Mehta (Paresh Prataprai)", "relation": "Joint Managing director", "url": "", "transactionDescription": "Other", "latestTransDate": "2016-04-13", "positionDirect": 0, "positionDirectDate": "2016-04-13"}, {"maxAge": 1, "name": "Mehta (Prataprai Keshavji)", "relation": "Non Executive Chairman", "url": "", "transactionDescription": "Sale", "latestTransDate": "2011-07-12", "positionDirect": 17965, "positionDirectDate": "2011-07-12"}, {"maxAge": 1, "name": "NBZ Pharma Ltd", "relation": "Promoter", "url": "", "transactionDescription": "Sale", "latestTransDate": "2012-09-18", "positionDirect": 0, "positionDirectDate": "2012-09-18"}], "maxAge": 1}, "calendarEvents": {"maxAge": 1, "earnings": {"earningsDate": ["2018-02-14 05:30:S", "2018-02-16 05:30:S"]}, "exDividendDate": "2019-09-20 05:30:00"}, "upgradeDowngradeHistory": {"history": [], "maxAge": 86400}, "price": {"maxAge": 1, "regularMarketChangePercent": 0.027589532, "regularMarketChange": 2.8499985, "regularMarketTime": "2021-04-30 15:29:59", "priceHint": 2, "regularMarketPrice": 106.15, "regularMarketDayHigh": 110.9, "regularMarketDayLow": 100.85, "regularMarketVolume": 39979, "averageDailyVolume10Day": 5758, "averageDailyVolume3Month": 7627, "regularMarketPreviousClose": 103.3, "regularMarketSource": "FREE_REALTIME", "regularMarketOpen": 103.3, "exchange": "NSI", "exchangeName": "NSE", "exchangeDataDelayedBy": 15, "marketState": "CLOSED", "quoteType": "EQUITY", "symbol": "KILITCH.NS", "underlyingSymbol": null, "shortName": "KILITCH DRUGS(INDI", "longName": "Kilitch Drugs (India) Limited", "currency": "INR", "quoteSourceName": "Delayed Quote", "currencySymbol": "\u20b9", "fromCurrency": null, "lastMarket": null, "marketCap": 1626430336}, "balanceSheetHistory": {"balanceSheetStatements": [{"maxAge": 1, "endDate": "2020-03-31", "cash": 27966000, "shortTermInvestments": 278104000, "netReceivables": 158844000, "inventory": 55567000, "otherCurrentAssets": 37272000, "totalCurrentAssets": 557856000, "longTermInvestments": 245864000, "propertyPlantEquipment": 383337000, "goodWill": 227487000, "intangibleAssets": 502000, "otherAssets": 13264000, "deferredLongTermAssetCharges": 9662000, "totalAssets": 1428310000, "accountsPayable": 71038000, "otherCurrentLiab": 7634000, "otherLiab": 3880000, "minorityInterest": 22183000, "totalCurrentLiabilities": 219721000, "totalLiab": 223601000, "commonStock": 154342000, "retainedEarnings": 632625000, "treasuryStock": 12296000, "capitalSurplus": 383263000, "otherStockholderEquity": 12296000, "totalStockholderEquity": 1182526000, "netTangibleAssets": 954537000}, {"maxAge": 1, "endDate": "2019-03-31", "cash": 79401000, "shortTermInvestments": 284162000, "netReceivables": 195463000, "inventory": 47158000, "otherCurrentAssets": 42146000, "totalCurrentAssets": 648783000, "longTermInvestments": 250196000, "propertyPlantEquipment": 287649000, "goodWill": 235914000, "intangibleAssets": 289000, "otherAssets": 13783000, "deferredLongTermAssetCharges": 10357000, "totalAssets": 1436614000, "accountsPayable": 43463000, "otherCurrentLiab": 42970000, "otherLiab": 4134000, "minorityInterest": 20966000, "totalCurrentLiabilities": 200941000, "totalLiab": 205075000, "commonStock": 153552000, "retainedEarnings": 633509000, "treasuryStock": 40249000, "capitalSurplus": 383263000, "otherStockholderEquity": 40249000, "totalStockholderEquity": 1210573000, "netTangibleAssets": 974370000}, {"maxAge": 1, "endDate": "2018-03-31", "cash": 47726000, "shortTermInvestments": 302934000, "netReceivables": 210125000, "inventory": 27964000, "otherCurrentAssets": 40592000, "totalCurrentAssets": 629816000, "longTermInvestments": 267853000, "propertyPlantEquipment": 109814000, "goodWill": 251357000, "intangibleAssets": 235000, "otherAssets": 17672000, "deferredLongTermAssetCharges": 15518000, "totalAssets": 1276747000, "accountsPayable": 77155000, "otherCurrentLiab": 49516000, "minorityInterest": 7313000, "totalCurrentLiabilities": 149161000, "totalLiab": 149161000, "commonStock": 137318000, "retainedEarnings": 604468000, "treasuryStock": 76174000, "capitalSurplus": 302313000, "otherStockholderEquity": 76174000, "totalStockholderEquity": 1120273000, "netTangibleAssets": 868681000}, {"maxAge": 1, "endDate": "2017-03-31", "cash": 22941000, "shortTermInvestments": 260187000, "netReceivables": 146089000, "inventory": 25952000, "otherCurrentAssets": 30003000, "totalCurrentAssets": 485674000, "longTermInvestments": 278027000, "propertyPlantEquipment": 86739000, "goodWill": 252765000, "intangibleAssets": 198000, "otherAssets": 25519000, "deferredLongTermAssetCharges": 24725000, "totalAssets": 1128922000, "accountsPayable": 56756000, "otherCurrentLiab": 43612000, "totalCurrentLiabilities": 116931000, "totalLiab": 116931000, "commonStock": 132318000, "retainedEarnings": 552944000, "treasuryStock": 48916000, "capitalSurplus": 277813000, "otherStockholderEquity": 48916000, "totalStockholderEquity": 1011991000, "netTangibleAssets": 759028000}], "maxAge": 86400}, "earningsTrend": {"trend": [{"maxAge": 1, "period": "0q", "endDate": null, "growth": {}, "earningsEstimate": {"avg": 0.0, "low": 0.0, "high": 0.0, "yearAgoEps": {}, "numberOfAnalysts": 0, "growth": {}}, "revenueEstimate": {"avg": 0, "low": 0, "high": 0, "numberOfAnalysts": 0, "yearAgoRevenue": {}, "growth": {}}, "epsTrend": {"current": 0.0, "7daysAgo": 0.0, "30daysAgo": 0.0, "60daysAgo": 0.0, "90daysAgo": 0.0}, "epsRevisions": {"upLast7days": 0, "upLast30days": 0, "downLast30days": 0, "downLast90days": {}}}, {"maxAge": 1, "period": "+1q", "endDate": null, "growth": {}, "earningsEstimate": {"avg": 0.0, "low": 0.0, "high": 0.0, "yearAgoEps": {}, "numberOfAnalysts": 0, "growth": {}}, "revenueEstimate": {"avg": 0, "low": 0, "high": 0, "numberOfAnalysts": 0, "yearAgoRevenue": {}, "growth": {}}, "epsTrend": {"current": 0.0, "7daysAgo": 0.0, "30daysAgo": 0.0, "60daysAgo": 0.0, "90daysAgo": 0.0}, "epsRevisions": {"upLast7days": 0, "upLast30days": 0, "downLast30days": 0, "downLast90days": {}}}, {"maxAge": 1, "period": "0y", "endDate": null, "growth": {}, "earningsEstimate": {"avg": 0.0, "low": 0.0, "high": 0.0, "yearAgoEps": {}, "numberOfAnalysts": 0, "growth": {}}, "revenueEstimate": {"avg": 0, "low": 0, "high": 0, "numberOfAnalysts": 0, "yearAgoRevenue": {}, "growth": {}}, "epsTrend": {"current": 0.0, "7daysAgo": 0.0, "30daysAgo": 0.0, "60daysAgo": 0.0, "90daysAgo": 0.0}, "epsRevisions": {"upLast7days": 0, "upLast30days": 0, "downLast30days": 0, "downLast90days": {}}}, {"maxAge": 1, "period": "+1y", "endDate": null, "growth": {}, "earningsEstimate": {"avg": 0.0, "low": 0.0, "high": 0.0, "yearAgoEps": {}, "numberOfAnalysts": 0, "growth": {}}, "revenueEstimate": {"avg": 0, "low": 0, "high": 0, "numberOfAnalysts": 0, "yearAgoRevenue": {}, "growth": {}}, "epsTrend": {"current": 0.0, "7daysAgo": 0.0, "30daysAgo": 0.0, "60daysAgo": 0.0, "90daysAgo": 0.0}, "epsRevisions": {"upLast7days": 0, "upLast30days": 0, "downLast30days": 0, "downLast90days": {}}}, {"maxAge": 1, "period": "+5y", "endDate": null, "growth": {}, "earningsEstimate": {"avg": {}, "low": {}, "high": {}, "yearAgoEps": {}, "numberOfAnalysts": {}, "growth": {}}, "revenueEstimate": {"avg": {}, "low": {}, "high": {}, "numberOfAnalysts": {}, "yearAgoRevenue": {}, "growth": {}}, "epsTrend": {"current": {}, "7daysAgo": {}, "30daysAgo": {}, "60daysAgo": {}, "90daysAgo": {}}, "epsRevisions": {"upLast7days": {}, "upLast30days": {}, "downLast30days": {}, "downLast90days": {}}}, {"maxAge": 1, "period": "-5y", "endDate": null, "growth": {}, "earningsEstimate": {"avg": {}, "low": {}, "high": {}, "yearAgoEps": {}, "numberOfAnalysts": {}, "growth": {}}, "revenueEstimate": {"avg": {}, "low": {}, "high": {}, "numberOfAnalysts": {}, "yearAgoRevenue": {}, "growth": {}}, "epsTrend": {"current": {}, "7daysAgo": {}, "30daysAgo": {}, "60daysAgo": {}, "90daysAgo": {}}, "epsRevisions": {"upLast7days": {}, "upLast30days": {}, "downLast30days": {}, "downLast90days": {}}}], "maxAge": 1}, "institutionOwnership": {"ownershipList": [], "maxAge": 1}, "majorHoldersBreakdown": {"maxAge": 1, "insidersPercentHeld": 0.72807, "institutionsPercentHeld": 0.0, "institutionsFloatPercentHeld": 0.0, "institutionsCount": 0}, "balanceSheetHistoryQuarterly": {"balanceSheetStatements": [{"maxAge": 1, "endDate": "2020-12-31", "totalStockholderEquity": 1219610000, "netTangibleAssets": 995845000}, {"maxAge": 1, "endDate": "2020-09-30", "cash": 11491000, "shortTermInvestments": 315667000, "netReceivables": 170126000, "inventory": 22127000, "otherCurrentAssets": 52211000, "totalCurrentAssets": 571622000, "longTermInvestments": 258027000, "propertyPlantEquipment": 761984000, "intangibleAssets": 223765000, "otherAssets": 29704000, "deferredLongTermAssetCharges": 13314000, "totalAssets": 1845102000, "accountsPayable": 409083000, "otherCurrentLiab": 20574000, "otherLiab": 33378000, "minorityInterest": 23964000, "totalCurrentLiabilities": 568150000, "totalLiab": 601528000, "commonStock": 154791000, "treasuryStock": 1064819000, "otherStockholderEquity": 1064819000, "totalStockholderEquity": 1219610000, "netTangibleAssets": 995845000}, {"maxAge": 1, "endDate": "2020-06-30", "totalStockholderEquity": 1182526000, "netTangibleAssets": 954537000}, {"maxAge": 1, "endDate": "2020-03-31", "cash": 27966000, "shortTermInvestments": 278104000, "netReceivables": 158844000, "inventory": 55567000, "otherCurrentAssets": 37272000, "totalCurrentAssets": 557856000, "longTermInvestments": 245864000, "propertyPlantEquipment": 383337000, "goodWill": 227487000, "intangibleAssets": 502000, "otherAssets": 13264000, "deferredLongTermAssetCharges": 9662000, "totalAssets": 1428310000, "accountsPayable": 71038000, "otherCurrentLiab": 7634000, "otherLiab": 3880000, "minorityInterest": 22183000, "totalCurrentLiabilities": 219721000, "totalLiab": 223601000, "commonStock": 154342000, "retainedEarnings": 632625000, "treasuryStock": 12296000, "capitalSurplus": 383263000, "otherStockholderEquity": 12296000, "totalStockholderEquity": 1182526000, "netTangibleAssets": 954537000}], "maxAge": 86400}, "earningsHistory": {"history": [{"maxAge": 1, "epsActual": {}, "epsEstimate": {}, "epsDifference": {}, "surprisePercent": {}, "quarter": {}, "period": "-4q"}, {"maxAge": 1, "epsActual": {}, "epsEstimate": {}, "epsDifference": {}, "surprisePercent": {}, "quarter": {}, "period": "-3q"}, {"maxAge": 1, "epsActual": {}, "epsEstimate": {}, "epsDifference": {}, "surprisePercent": {}, "quarter": {}, "period": "-2q"}, {"maxAge": 1, "epsActual": {}, "epsEstimate": {}, "epsDifference": {}, "surprisePercent": {}, "quarter": {}, "period": "-1q"}], "maxAge": 86400}, "summaryProfile": {"address1": "37/39, Ujagar Industrial Estate", "address2": "Waman Tukaram Patil Marg Deonar", "city": "Mumbai", "zip": "400088", "country": "India", "phone": "91 22 6121 4100", "fax": "91 22 6703 1658", "website": "http://www.kilitch.com", "industry": "Drug Manufacturers\u2014General", "sector": "Healthcare", "longBusinessSummary": "Kilitch Drugs (India) Limited engages in the development and operation of pharmaceutical business in India. The company offers parenteral and nasal products, including gastroenterology, anti-inflammatory, anticonvulsant/antiepileptic, anti-malarial, aminoglycoside, antibacterial, anti-hypertensive, anti-infective, diagnostic, sympathomimetic, local anesthetic, neurotonic, uterine stimulant, external preparation, non-steroidal anti-inflammatory, oncology, ophthalmic, and other drugs, as well as vaccines and veterinary products in the form of ampoules, vials, and dry powder injectables. Its parenteral and nasal products also include iron supplements for the treatment of anemia; and metered nasal drops, as well as Klavmox and Onecef products. The company also provides a range of oral formulations, including tablets, capsules, dry syrups, gripe water, and oral powders and liquids in the antibiotic, anti-diabetics, cardiovascular, and other areas. In addition, it offers effervescent tablets and powders, such as ROIPAR, DUREGRA, ROIVIT, and PH-7; and a range of nutritional products comprising CELTINE. Further, the company provides C-Seal, a topical skin adhesive to hold closely approximated skin edges without marks of sutures and incisions. Additionally, it offers cosmetics and herbal products consisting of a range of oils, lotions, liquids, creams, and paste in skin, personal, and hair care categories, as well as herbal products used in sore throat and prostate problems; and as a supplement for diabetes, obesity, libido, and other conditions. The company also exports its products. Kilitch Drugs (India) Limited was founded in 1978 and is headquartered in Mumbai, India.", "fullTimeEmployees": 111, "companyOfficers": [], "maxAge": 86400}, "netSharePurchaseActivity": {"maxAge": 1, "period": "6m", "buyInfoCount": 0, "buyInfoShares": 0, "sellInfoCount": 0, "netInfoCount": 0, "netInfoShares": 0, "netPercentInsiderShares": 0.0, "totalInsiderShares": 11275411}, "insiderTransactions": {"transactions": [{"maxAge": 1, "shares": 676116, "filerUrl": "", "transactionText": "", "filerName": "Mehta (Mukund Prataprai)", "filerRelation": "Managing Director", "moneyText": "", "startDate": "2019-06-27", "ownership": "D"}, {"maxAge": 1, "shares": 1649116, "filerUrl": "", "transactionText": "", "filerName": "Mehta (Bhavin)", "filerRelation": "Wholetime Director", "moneyText": "", "startDate": "2019-06-27", "ownership": "D"}, {"maxAge": 1, "shares": 60000, "filerUrl": "", "transactionText": "", "filerName": "Mehta (Mukund Prataprai)", "filerRelation": "Managing Director", "moneyText": "", "startDate": "2018-03-29", "ownership": "D"}, {"maxAge": 1, "shares": 190000, "filerUrl": "", "transactionText": "", "filerName": "Mehta (Neeta Mukund)", "filerRelation": "Promoter", "moneyText": "", "startDate": "2018-03-29", "ownership": "D"}, {"maxAge": 1, "shares": 250000, "filerUrl": "", "transactionText": "", "filerName": "Mehta (Bhavin)", "filerRelation": "Wholetime Director", "moneyText": "", "startDate": "2018-03-29", "ownership": "D"}, {"maxAge": 1, "shares": 956785, "filerUrl": "", "transactionText": "", "filerName": "Mehta (Mukund Prataprai)", "filerRelation": "Managing Director", "moneyText": "", "startDate": "2016-04-13", "ownership": "D"}, {"maxAge": 1, "shares": 956785, "filerUrl": "", "transactionText": "", "filerName": "Mehta (Paresh Prataprai)", "filerRelation": "Joint Managing director", "moneyText": "", "startDate": "2016-04-13", "ownership": "D"}, {"maxAge": 1, "shares": 299318, "filerUrl": "", "transactionText": "", "filerName": "Mehta (Mukund Prataprai)", "filerRelation": "Managing Director", "moneyText": "", "startDate": "2012-09-21", "ownership": "D"}, {"maxAge": 1, "shares": 299317, "filerUrl": "", "transactionText": "", "filerName": "Mehta (Paresh Prataprai)", "filerRelation": "Joint Managing director", "moneyText": "", "startDate": "2012-09-21", "ownership": "D"}, {"maxAge": 1, "shares": 616600, "filerUrl": "", "transactionText": "", "filerName": "Kilitch Company Pharma Ltd", "filerRelation": "Institution- Corporation", "moneyText": "", "startDate": "2012-09-21", "ownership": "D"}, {"maxAge": 1, "shares": 6012742, "filerUrl": "", "transactionText": "", "filerName": "Kilitch Company Pharma Ltd", "filerRelation": "Promoter", "moneyText": "", "startDate": "2012-09-18", "ownership": "D"}, {"maxAge": 1, "shares": 6012742, "filerUrl": "", "transactionText": "", "filerName": "NBZ Pharma Ltd", "filerRelation": "Promoter", "moneyText": "", "startDate": "2012-09-18", "ownership": "D"}, {"maxAge": 1, "shares": 600000, "filerUrl": "", "transactionText": "", "filerName": "Mehta (Prataprai Keshavji)", "filerRelation": "Non Executive Chairman", "moneyText": "", "startDate": "2011-07-12", "ownership": "D"}, {"maxAge": 1, "shares": 406296, "filerUrl": "", "transactionText": "", "filerName": "Mehta (Paresh Prataprai)", "filerRelation": "Joint Managing director", "moneyText": "", "startDate": "2011-07-12", "ownership": "D"}, {"maxAge": 1, "shares": 193704, "filerUrl": "", "transactionText": "", "filerName": "Mehta (Mukund Prataprai)", "filerRelation": "Managing Director", "moneyText": "", "startDate": "2011-07-12", "ownership": "D"}], "maxAge": 1}, "sectorTrend": {"maxAge": 1, "symbol": null, "estimates": []}, "incomeStatementHistoryQuarterly": {"incomeStatementHistory": [{"maxAge": 1, "endDate": "2020-12-31", "totalRevenue": 203274000, "costOfRevenue": 101375000, "grossProfit": 101899000, "researchDevelopment": {}, "sellingGeneralAdministrative": 21766000, "nonRecurring": {}, "otherOperatingExpenses": 49936000, "totalOperatingExpenses": 178089000, "operatingIncome": 25185000, "totalOtherIncomeExpenseNet": 2471000, "ebit": 25185000, "interestExpense": -1213000, "incomeBeforeTax": 27656000, "incomeTaxExpense": 5817000, "minorityInterest": {}, "netIncomeFromContinuingOps": 21839000, "discontinuedOperations": {}, "extraordinaryItems": {}, "effectOfAccountingCharges": {}, "otherItems": {}, "netIncome": 22146000, "netIncomeApplicableToCommonShares": 22146000}, {"maxAge": 1, "endDate": "2020-09-30", "totalRevenue": 180720000, "costOfRevenue": 85275000, "grossProfit": 95445000, "researchDevelopment": {}, "sellingGeneralAdministrative": 20881000, "nonRecurring": {}, "otherOperatingExpenses": 44989000, "totalOperatingExpenses": 156103000, "operatingIncome": 24617000, "totalOtherIncomeExpenseNet": 2437000, "ebit": 24617000, "interestExpense": -1784000, "incomeBeforeTax": 27054000, "incomeTaxExpense": 4975000, "minorityInterest": 23964000, "netIncomeFromContinuingOps": 22079000, "discontinuedOperations": {}, "extraordinaryItems": {}, "effectOfAccountingCharges": {}, "otherItems": {}, "netIncome": 20817000, "netIncomeApplicableToCommonShares": 20817000}, {"maxAge": 1, "endDate": "2020-06-30", "totalRevenue": 101917000, "costOfRevenue": 72230000, "grossProfit": 29687000, "researchDevelopment": {}, "sellingGeneralAdministrative": 16566000, "nonRecurring": {}, "otherOperatingExpenses": 24243000, "totalOperatingExpenses": 117894000, "operatingIncome": -15977000, "totalOtherIncomeExpenseNet": 763000, "ebit": -15977000, "interestExpense": -2932000, "incomeBeforeTax": -15214000, "incomeTaxExpense": -1877000, "minorityInterest": 23964000, "netIncomeFromContinuingOps": -13337000, "discontinuedOperations": {}, "extraordinaryItems": {}, "effectOfAccountingCharges": {}, "otherItems": {}, "netIncome": -13337000, "netIncomeApplicableToCommonShares": -13337000}, {"maxAge": 1, "endDate": "2020-03-31", "totalRevenue": 116231000, "costOfRevenue": 68500000, "grossProfit": 47731000, "researchDevelopment": {}, "sellingGeneralAdministrative": 29435000, "nonRecurring": {}, "otherOperatingExpenses": 40180000, "totalOperatingExpenses": 134933000, "operatingIncome": -18702000, "totalOtherIncomeExpenseNet": 2828000, "ebit": -18702000, "interestExpense": -2303000, "incomeBeforeTax": -15874000, "incomeTaxExpense": -3402000, "minorityInterest": 22183000, "netIncomeFromContinuingOps": -12472000, "discontinuedOperations": {}, "extraordinaryItems": {}, "effectOfAccountingCharges": {}, "otherItems": {}, "netIncome": -12472000, "netIncomeApplicableToCommonShares": -12472000}], "maxAge": 86400}, "cashflowStatementHistoryQuarterly": {"cashflowStatements": [{"maxAge": 1, "endDate": "2020-12-31", "netIncome": 22146000, "changeToLiabilities": 0}, {"maxAge": 1, "endDate": "2020-09-30", "netIncome": 20817000, "changeToLiabilities": 0}, {"maxAge": 1, "endDate": "2020-06-30", "netIncome": -13337000, "changeToLiabilities": 0}, {"maxAge": 1, "endDate": "2020-03-31", "netIncome": -12472000, "changeToLiabilities": 0}], "maxAge": 86400}, "earnings": {"maxAge": 86400, "earningsChart": {"quarterly": [], "earningsDate": ["2018-02-14 05:30:S", "2018-02-16 05:30:S"]}, "financialsChart": {"yearly": [{"date": 2017, "revenue": 286525000, "earnings": -88896000}, {"date": 2018, "revenue": 510118000, "earnings": 51526000}, {"date": 2019, "revenue": 824899000, "earnings": 38298000}, {"date": 2020, "revenue": 533200000, "earnings": 8420000}], "quarterly": [{"date": "1Q2020", "revenue": 116231000, "earnings": -12472000}, {"date": "2Q2020", "revenue": 101917000, "earnings": -13337000}, {"date": "3Q2020", "revenue": 180720000, "earnings": 20817000}, {"date": "4Q2020", "revenue": 203274000, "earnings": 22146000}]}, "financialCurrency": "INR"}, "financialData": {"maxAge": 86400, "currentPrice": 106.15, "targetHighPrice": 47.0, "targetLowPrice": 47.0, "targetMeanPrice": 47.0, "targetMedianPrice": 47.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 327158016, "totalCashPerShare": 21.125, "ebitda": 26350250, "totalDebt": 138492992, "totalRevenue": 602142016, "debtToEquity": 11.137, "revenuePerShare": 38.763, "grossProfits": 235468000, "earningsGrowth": 1.306, "revenueGrowth": 0.276, "grossMargins": 0.45631, "ebitdaMargins": 0.043759998, "operatingMargins": 0.025120001, "profitMargins": 0.02849, "financialCurrency": "INR"}}}